adamantinous craniopharyngioma
adamantinous craniopharyngioma
Explore linked clinical trials. Standard reference: MONDO:00027873 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| FOG-001 in Locally Advanced or Metastatic Solid Tumors | Adenomatous Polyps, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cronkhite-Canada syndrome, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Liver Neoplasms, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, adamantinous craniopharyngioma, adenocarcinoma, adenoma, cancer, carcinoma, classic familial adenomatous polyposis, colonic disorder, colorectal cancer, colorectal neoplasm, connective tissue neoplasm, craniopharyngioma, desmoid tumor, digestive system disorder, digestive system neoplasm, endometrial carcinoma, endometrium neoplasm, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, fibroma, hepatocellular carcinoma, hereditary disease, hereditary neoplastic syndrome, intestinal disorder, liver disorder, male reproductive organ cancer, male reproductive system disorder, metastatic malignant neoplasm, neoplasm, primitive neuroectodermal tumor, prostate cancer, prostate disorder, rectal disorder, uterine disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-07 | NCT05919264 | |
| ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adamantinous craniopharyngioma, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-04-23 | NCT05233397 | |
| Tocilizumab in Children With ACP | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adamantinous craniopharyngioma, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Early phase 1 | 2026-02-17 | NCT03970226 |